Terms: = Lung cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
863 results:
1. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
[TBL] [Abstract] [Full Text] [Related]
2. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
Gan DEH; Bustam AZ
J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
[TBL] [Abstract] [Full Text] [Related]
3. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract] [Full Text] [Related]
4. Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
Rigon M; Mutti L; Campanella M
Mol Oncol; 2024 Apr; 18(4):797-814. PubMed ID: 38459714
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Liu J; Zhu L; Tang M; Huang X; Gu C; He C; Lv X; Hu J
Sci Rep; 2024 Mar; 14(1):5523. PubMed ID: 38448498
[TBL] [Abstract] [Full Text] [Related]
6. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Recurrent Breast cancer That Was brca1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor].
Aoyagi T; Namura M; Sakata H; Tamanuki T; Iwai M; Iwata K; Takahashi H; Matsuzaki H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1462-1464. PubMed ID: 38303308
[TBL] [Abstract] [Full Text] [Related]
8. Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors.
Kim C; Wang XD; Liu Z; Hao J; Wang S; Li P; Zi Z; Ding Q; Jang S; Kim J; Luo Y; Huffman KE; Pal Choudhuri S; Del Rio S; Cai L; Liang H; Drapkin BJ; Minna JD; Yu Y
Sci Adv; 2024 Jan; 10(3):eadh2579. PubMed ID: 38241363
[TBL] [Abstract] [Full Text] [Related]
9. Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Madorsky Rowdo FP; Xiao G; Khramtsova GF; Nguyen J; Martini R; Stonaker B; Boateng R; Oppong JK; Adjei EK; Awuah B; Kyei I; Aitpillah FS; Adinku MO; Ankomah K; Osei-Bonsu EB; Gyan KK; Altorki NK; Cheng E; Ginter PS; Hoda S; Newman L; Elemento O; Olopade OI; Davis MB; Martin ML; Bargonetti J
Cancer Lett; 2024 Mar; 584():216608. PubMed ID: 38199587
[TBL] [Abstract] [Full Text] [Related]
10. Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
Chen S; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Ye T; Chen H
Thorac Cancer; 2024 Jan; 15(3):258-265. PubMed ID: 38098268
[TBL] [Abstract] [Full Text] [Related]
11. Intraocular medulloepithelioma: an unusual and challenging entity in paediatric population.
Imam U; Hameed M; Anis I; Bhutto I; Ahmed SH; Rizvi A; Ahmad Z
J Pak Med Assoc; 2023 Dec; 73(12):2469-2472. PubMed ID: 38083935
[TBL] [Abstract] [Full Text] [Related]
12. Non-coplanar lung SABR treatments delivered with a gantry-mounted x-ray tube.
O'Connell J; Weil MD; Bazalova-Carter M
Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38035372
[No Abstract] [Full Text] [Related]
13. Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell lung cancer Cell Line H1975.
Tong X; Zhang R; Sun R; Yang W; Sun J; Chen J; Li F
Anticancer Res; 2023 Dec; 43(12):5459-5474. PubMed ID: 38030186
[TBL] [Abstract] [Full Text] [Related]
14. Rate of Pathogenic Germline Variants in Patients With lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
15. Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.
Takeda K; Bastacky S; Dhir R; Mohebnasab M; Quiroga-Garza GM
Ann Diagn Pathol; 2024 Feb; 68():152223. PubMed ID: 37976977
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
Stålhammar G
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
[TBL] [Abstract] [Full Text] [Related]
17. Enhancing Symptom Screening and Patient Education Among Patients with Metastatic lung cancer: a Qualitative Analysis.
Safavi AH; Bryson E; Delibasic V; Tjong MC; Hallet J; Mahar A; Davis LE; Wright FC; Parmar A; Coburn NG; Louie AV
J Cancer Educ; 2024 Feb; 39(1):86-95. PubMed ID: 37962792
[TBL] [Abstract] [Full Text] [Related]
18. Pathogenic germline variants in brca1 and TP53 increase lung cancer risk in Chinese.
Wei B; Zhao J; Li J; Feng J; Sun M; Wang Z; Shi C; Yang K; Qin Y; Zhang J; Ma J; Dong H
Cancer Med; 2023 Dec; 12(23):21219-21228. PubMed ID: 37930190
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
Aydogdu G; Özekinci S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370
[TBL] [Abstract] [Full Text] [Related]
20. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant lung cancer.
Stockhammer P; Grant M; Wurtz A; Foggetti G; Expósito F; Gu J; Zhao H; Choi J; Chung S; Li F; Walther Z; Dietz J; Duffield E; Gettinger S; Politi K; Goldberg SB
J Thorac Oncol; 2024 Feb; 19(2):240-251. PubMed ID: 37806385
[TBL] [Abstract] [Full Text] [Related]
[Next]
